1. Home
  2. TNDM vs RXO Comparison

TNDM vs RXO Comparison

Compare TNDM & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
  • RXO
  • Stock Information
  • Founded
  • TNDM 2006
  • RXO 2022
  • Country
  • TNDM United States
  • RXO United States
  • Employees
  • TNDM 2650
  • RXO N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • RXO
  • Sector
  • TNDM Health Care
  • RXO
  • Exchange
  • TNDM Nasdaq
  • RXO Nasdaq
  • Market Cap
  • TNDM 1.1B
  • RXO N/A
  • IPO Year
  • TNDM 2013
  • RXO N/A
  • Fundamental
  • Price
  • TNDM $16.86
  • RXO $13.24
  • Analyst Decision
  • TNDM Buy
  • RXO Hold
  • Analyst Count
  • TNDM 16
  • RXO 17
  • Target Price
  • TNDM $44.44
  • RXO $23.00
  • AVG Volume (30 Days)
  • TNDM 1.5M
  • RXO 1.7M
  • Earning Date
  • TNDM 04-30-2025
  • RXO 05-07-2025
  • Dividend Yield
  • TNDM N/A
  • RXO N/A
  • EPS Growth
  • TNDM N/A
  • RXO N/A
  • EPS
  • TNDM N/A
  • RXO N/A
  • Revenue
  • TNDM $940,203,000.00
  • RXO $4,550,000,000.00
  • Revenue This Year
  • TNDM $8.59
  • RXO $45.19
  • Revenue Next Year
  • TNDM $10.87
  • RXO $7.98
  • P/E Ratio
  • TNDM N/A
  • RXO N/A
  • Revenue Growth
  • TNDM 25.74
  • RXO 15.87
  • 52 Week Low
  • TNDM $15.75
  • RXO $12.39
  • 52 Week High
  • TNDM $53.69
  • RXO $32.82
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 33.57
  • RXO 31.98
  • Support Level
  • TNDM $16.30
  • RXO $12.70
  • Resistance Level
  • TNDM $17.73
  • RXO $14.33
  • Average True Range (ATR)
  • TNDM 1.11
  • RXO 1.35
  • MACD
  • TNDM 0.28
  • RXO -0.21
  • Stochastic Oscillator
  • TNDM 29.92
  • RXO 11.71

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: